In DTCs obtained by treating EGFR-mutated non-small cell lung cancer cells (NSCLC) with gefitinib, a significant upregulation of the mTOR-mediated anti-apoptotic protein MCL1 could be found, indicating that DTCs are closely associated with anti-apoptosis (24). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.